"/> Novus Biologicals™ Peptide bloquant d’anticorps SP… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps SP110

Réf. : BL-RE-083117Réf. fabricant : 18269015 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
3431
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77316. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the carboxy terminus of human IPR1.

Points forts

Source

Synthetic

(Accession #: NP_004501) The SP110 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-083117
Réf. fabricant18269015
Gene ID (Entrez)3431
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77316. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneFLJ22835, IFI41, IFI75, interferon-induced protein 41, 30 kD, Interferon-induced protein 41/75, interferon-induced protein 75, 52 kD, IPR1, phosphoprotein 41, phosphoprotein 75, SP110 nuclear body protein, Speckled 110 kDa, Transcriptional coactivator Sp110, VODI
Symbole de gène(s)SP110
Type de produitSP110
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human IPR1
Une question, une configuration particulière ?
Contactez-nous pour un devis.